After transfecting LV-CBX7, debilitated ability of invasion was demonstrated by transwell assay and counted into the bar graph. (C-D) After transfecting LV-CBX7, poor ability of migration was detected by wound-healing assay and counted into bar graph. (E) Three-dimensional spheroid assays was carried out to display invasive ability after overexpressing CBX7. (F-I) Cells were transfected with CBX7, and the levels of cell EMT relative proteins including Vimentin, N-Cadherin, E-Cadherin were detected by western blot analysis. β-actin was used as an endogenous normalizer. (J) Western blot assay was used to show decreased expression of MMP2 and MMP9 in PGC/CBX7 stabled cells. β-actin was used as an endogenous normalizer. (K) The effect of CBX7 on the Wnt signaling pathway was analyzed by immunoblotting with the indicated antibodies. (L) PGC cells were stained with an anti-β-catenin antibody (red) and DAPI (blue). (M) Cells were fractionated, and the nuclear and cytoplasmic extracts were subjected to immunoblotting. GAPDH and H3 were used as controls for the cytoplasmic and nuclear, respectively. (N) ZEB1 expression in PGC/CBX7 stabled cells were subjected to immunoblotting. β-actin was used as an endogenous normalizer. (O) The expression of other EMT markers such as Slug, Snail, Twist and ZO-1 were detected by WB in PGC/CBX7 stabled cells. All experiments were performed in triplicate. * P<0.05; ** P < 0.01 and *** P < 0.001. 
